EUVIMEDDescoperă EUVIMED
Open access

Calycosin attenuates mitochondrial damage and pyroptosis in heart failure via the Nrf2/ROS/TXNIP pathway

Hua-Jing Yuan, Quan-Cheng Han, Yi-Ding Yu, Hui Yu, Xiu-Juan Liu, Yi-Tao Xue, Yan Li

International Journal of Molecular Medicine · 2025

DOI: 10.3892/ijmm.2025.5653 ↗

At a glance

Journal article in International Journal of Molecular Medicine, 2025. Written by Hua-Jing Yuan and 6 co-authors. Institution: The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China. Major MEDLINE topics: NF-E2-Related Factor 2, Pyroptosis, Isoflavones, Heart Failure. Cited 6 times so far (Crossref); 52 references. The full text is freely available in PubMed Central.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Heart failure (HF) is a key public health concern worldwide due to its high morbidity and mortality rates. Calycosin (CA) is a flavonoid natural product that effectively treats HF with cardioprotective effects; however, its mechanism of action remains unclear. The present study aimed to investigate the therapeutic effect of CA on HF and its mechanism through in vivo and in vitro experiments, and to reveal the roles of pyroptosis and mitochondrial dysfunction in the pathophysiology of HF. The HF model was constructed 4 weeks after ligation of the left anterior descending artery in rats. Myocardial ischemia‑reperfusion injury was simulated using a hypoxia‑reoxygenation model and nuclear factor erythroid 2‑related factor (Nrf2) was silenced by transfection using small interfering RNA to further explore the therapeutic mechanism of CA. The results revealed that CA treatment improved cardiac function and myocardial injury, suppressed oxidative stress levels and improved mitochondrial ultrastructure in HF‑induced rats. CA downregulated the expression of relevant pyroptosis proteins via the Nrf2/reactive oxygen species (ROS)/thioredoxin‑interacting protein (TXNIP) pathway. In vitro experiments demonstrated consistent results confirming that CA ameliorated mitochondrial damage by reducing levels of ROS and inhibiting mitochondrial gasdermin D N‑terminal fragments activation. Silencing Nrf2 partially reversed the cardioprotective effects of CA, confirming the key therapeutic role of CA in Nrf2‑mediated anti‑pyroptosis. In conclusion, CA inhibits pyroptosis and improves mitochondrial damage in HF through the Nrf2/ROS/TXNIP pathway, which may disrupt the crosstalk between mitochondrial damage and pyroptosis, thereby exerting cardioprotective effects.

Subjects

MeSH terms (MEDLINE)

NF-E2-Related Factor 2PyroptosisIsoflavonesHeart FailureReactive Oxygen SpeciesSignal TransductionMitochondriaAnimalsMaleRatsRats, Sprague-DawleyOxidative StressMyocardial Reperfusion InjuryDisease Models, Animal

Author keywords

CAHFNrf2ROSTXNIPmitochondrial damagepyroptosis

Substances

NF-E2-Related Factor 2IsoflavonesReactive Oxygen Species7,3'-dihydroxy-4'-methoxyisoflavoneNfe2l2 protein, rat

Authors and institutions

  • The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China.
  • Department of Cardiology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China.

Cite

APA

Yuan, H. J., Han, Q. C., Yu, Y. D., Yu, H., Liu, X. J., Xue, Y. T., & Li, Y. (2025). Calycosin attenuates mitochondrial damage and pyroptosis in heart failure via the Nrf2/ROS/TXNIP pathway. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2025.5653

Vancouver

Yuan HJ, Han QC, Yu YD, Yu H, Liu XJ, Xue YT, et al. Calycosin attenuates mitochondrial damage and pyroptosis in heart failure via the Nrf2/ROS/TXNIP pathway. International Journal of Molecular Medicine. 2025. doi:10.3892/ijmm.2025.5653

BibTeX
@article{Yuan2025,
  author = {Yuan, Hua-Jing and Han, Quan-Cheng and Yu, Yi-Ding and Yu, Hui and Liu, Xiu-Juan and Xue, Yi-Tao and Li, Yan},
  title = {Calycosin attenuates mitochondrial damage and pyroptosis in heart failure via the Nrf2/ROS/TXNIP pathway},
  journal = {International Journal of Molecular Medicine},
  year = {2025},
  doi = {10.3892/ijmm.2025.5653}
}
Start for free →